Novigenix is a precision medicine company that specializes in ImmunoTranscriptomic solutions.
Technology: Immunotherapy
Industry: AI
Headquarters: Epalinges, Vaud, Switzerland
Founded Date: 01.01.2014
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 1
Total Funding: 21108513
Estimated Revenue: $1M to $10M
Last Funding Date: 15.11.2022
Last Funding Type: Series B

Visit Website
Register and Claim Ownership